Work

Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system ( FAERS ) from 2022 to 2023

Year: 2024

Type: article

Study design: Observational Study

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.20197

Authors: Hannah Godfrey, Zachary Leibovit‐Reiben, Patrick Jedlowski, Rebecca Thiede

Institution: University of Arizona

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400012935

FWCI: 39.22

Cites: 8

Cited by: 52

Related to: 10